Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ideal For: Those looking to tailor their GH release patterns, often combining with other peptides like Ipamorelin for enhanced and synergistic effects
Preclinical work and early clinical trials indicate preferential intratumoral accumulation, sustained inhibition of topoisomerase I and hypoxia-inducible factor 1 alpha (HIF-1), and downregulation of HIF-1-related markers such as carbonic anhydrase IX in human tumor biopsies [90,91,92]
Cancer history or active malignancy concerns need clinician review before GH-axis stimulation is considered
10.1016/j.ijbiomac.2024.132256 47 YabeD.KawamoriD.SeinoY.OuraT.TakeuchiM
Space treatments 12 weeks apart and consult your dermatologist to ensure treatment compatibility and safety
:max_bytes(150000):strip_icc()/3231861_color1-5c01780b46e0fb0001e3a02b.png)
